Skip to main content
. 2022 Jun 30;11(6):2437–2441. doi: 10.4103/jfmpc.jfmpc_1746_21

Table 3.

SGPT and SGOT in patients with acute viral hepatitis due to HAV and HEV

SGOT/AST HAV (106) (Mean-388.52) HEV (128) (Mean- 241.66) SGPT/ALT HAV (106) (Mean-336.57) HEV (128) (Mean-295.51)
1-40 (Normal) 14 (13.20%) 8 (6.25%) 1-40 (Normal) 9 (8.49%) 42 (32.8%)
41-1000 81 (76.4%) 117 (91.4%) 41-1000 93 (87.73%) 82 (64.06%)
1001-2000 10 (9.43%) 3 (2.34%) 1001-2000 3 (2.83%) 3 (2.34%)
2001-3000 0 0 2001-3000 0 1 (0.78%)
>3000 1 (0.94%) 0 >3000 1 (0.94%) 0

*SGOT/AST - Serum glutamic oxaloacetic transaminase /aspartate aminotransferase (AST), SGPT/ALT - Serum glutamic pyruvic transaminase/ alanine aminotransferase (ALT)